8-K: Diversified Healthcare Trust Reports Q2 2026 Results

Diversified Healthcare Trust announced its second quarter 2026 financial results, highlighting operational improvements in its Senior Housing Operating Portfolio (SHOP) segment and a reduction in net debt to Adjusted EBITDAre.

Summary

• Diversified Healthcare Trust (DHC) reported its financial results for the second quarter ended June 30, 2026.
• The company saw significant year-over-year growth in its Senior Housing Operating Portfolio (SHOP) segment, with Same Property Cash Basis NOI increasing by 37.2% to $51.975 million.
• SHOP segment NOI margins improved to 17.3%, up 390 basis points year-over-year and 240 basis points sequentially.
• The Medical Office and Life Science Portfolio maintained strong occupancy at 95.8%, with new and renewal leasing completed at rents 6.7% higher than prior levels.
• Net debt to annualized Adjusted EBITDAre improved to 7.1x, down from 7.8x in the previous quarter and 8.7x a year ago.
• The company reported a net loss of $37.4 million, or $(0.16) per share, for the quarter.
• Normalized FFO was $38.9 million, or $0.16 per share, representing 109.4% year-over-year growth.
• Full year 2026 financial guidance was provided, with updated assumptions for SHOP NOI growth and operating expenses.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive report, with significant operational improvements in the SHOP segment and a strengthening balance sheet, though the overall financial performance still shows a net loss.

Positives

• Same Property SHOP NOI growth of 37.2% year-over-year, reaching $51.975 million.
• SHOP segment NOI margins increased to 17.3%, a 390 basis point improvement year-over-year.
• Medical Office and Life Science Portfolio occupancy remained strong at 95.8%.
• Leasing activity in the Medical Office and Life Science Portfolio saw rents increase by 6.7% on new and renewal leases.
• Net debt to annualized Adjusted EBITDAre improved to 7.1x, indicating deleveraging.
• Normalized FFO per share grew by 109.4% year-over-year to $0.16.
• Total liquidity stood at $266.8 million as of June 30, 2026.

Negatives

• The company reported a net loss of $37.4 million for the second quarter of 2026.
• Net loss per common share was $(0.16) for the quarter.
• While improving, the Net Debt to Annualized Adjusted EBITDAre ratio of 7.1x still indicates a significant debt load relative to earnings.
• NOI from the Medical Office and Life Science Portfolio declined by 2.6% year-over-year.

Risks

• The company's forward-looking statements are subject to risks and uncertainties, including unfavorable market and commercial real estate conditions, uncertainties surrounding interest rates, inflation, supply chain disruptions, and economic downturns.
• The financial strength of DHC's managers, operators, and tenants is a risk factor.
• Changes in market practices, such as reduced demand for leased space and increased operating costs, pose a risk.
• The company faces risks related to its ability to manage capital expenditures and operating costs effectively.
• Compliance with financial covenants under debt agreements and maintaining sufficient liquidity are ongoing risks.
• Potential conflicts of interest with related parties, including Managing Trustees and RMR, are noted.
• The company's ability to maintain its qualification for taxation as a REIT is subject to complex rules.

Future Outlook

Full year 2026 financial guidance is consistent with the news release issued on June 1, 2026, with a mid-point increase of $10,000 in SHOP NOI, Adjusted EBITDAre, and Normalized FFO. The guidance reflects assumptions for year-over-year occupancy growth of approximately 200 bps, revenue growth of approximately 6.6%, and operating expense growth of approximately 2.5% in the SHOP segment.

Management Comments

• "DHC's strong second quarter results reflect the meaningful progress we have made across the portfolio as the SHOP operator transitions we implemented over the past year continue to drive improved performance."
• "These gains reflect the disciplined execution of our operators, which helped drive same property SHOP NOI growth of 37.2% year over year to $52.0 million."
• "As we look ahead, we remain focused on executing operational improvements across the SHOP segment, advancing portfolio optimization initiatives and prudently deploying capital to support long-term earnings growth."
• "The momentum we are seeing across our portfolio reinforces the confidence we have in our business plan and we remain focused on maximizing value for our shareholders."

Industry Context

StockSavvy.ai notes that DHC's performance in the SHOP segment aligns with broader trends of recovery and operational efficiency gains in senior housing following recent industry challenges. The continued strength in Medical Office and Life Science properties reflects sustained demand for these asset classes.

Comparison to Industry Standards

• The Same Property SHOP NOI growth of 37.2% is a strong indicator of operational recovery and outperformance within the senior housing sector, which has faced headwinds.
• The Medical Office and Life Science Portfolio occupancy of 95.8% is generally considered very high and competitive within the healthcare real estate sector.
• The increase in leasing rates of 6.7% for Medical Office and Life Science properties suggests a favorable leasing environment for these assets, potentially outperforming broader commercial real estate leasing trends.
• The Net Debt to Annualized Adjusted EBITDAre ratio of 7.1x is on the higher side for REITs, but the trend of improvement (down from 7.8x and 8.7x) is positive and aligns with efforts to strengthen the balance sheet, a common focus for companies in this sector.

Related Party Transactions

• DHC is managed by The RMR Group (RMR), which provides management services at a cost DHC believes is lower than self-management.
• Incentive management fees are paid to RMR, with $9,993 recognized for the three months ended June 30, 2026.

Stakeholder Impact

• Shareholders: The company declared a quarterly distribution of $0.01 per share, indicating a return of capital, though the net loss and Normalized FFO payout ratio (6.3%) should be considered.
• Creditors: The improvement in leverage ratios (Net Debt to Adjusted EBITDAre) is positive for debt holders, indicating reduced financial risk.
• Tenants/Residents: Continued operational improvements and leasing success in Medical Office and Life Science properties, along with positive trends in SHOP occupancy and rates, are beneficial for tenants and residents.
• Management/Employees: The focus on operational improvements and strategic initiatives suggests continued efforts to drive performance and value.

Next Steps

• Continue executing operational improvements across the SHOP segment.
• Advance portfolio optimization initiatives.
• Prudently deploy capital to support long-term earnings growth.
• Focus on maximizing value for shareholders.

Key Dates

Recommendation

The company shows positive operational momentum, particularly in the SHOP segment, and is improving its balance sheet. However, the persistent net loss and the still elevated leverage ratios warrant a cautious approach. The guidance is in line with expectations, suggesting no immediate catalyst for a significant upward re-rating, but the operational improvements provide a floor. Therefore, a 'hold' recommendation is appropriate pending further sustained improvement and profitability.

Keywords

Diversified Healthcare Trust, Healthcare REIT, Senior Housing, Medical Office, Life Science, Real Estate Investment Trust, Q2 2026, Financial Results